FIELD: chemistry; biochemistry.
SUBSTANCE: invention relates to biotechnology, in particular, to immunoengineering, and may be used in digital processing of images of lysed zones on bacterial lawn, which result from antigen-antibody reaction, based on phage label principle (phagoimmunoassay or viroimmunoassay). Phagoimmunoassay results evaluation method implies analysis of lysed zones of indicator crop in plate wells with experimental and reference tests. Plate with experimental and reference tests is subsequently placed into photo or scanning unit to obtain digitised image of lysed zones. Then, each digitised image is processed by means of adaptive filter to obtain outlined individual lysed zones of various size, as well as of merged lysed zones. After that, average total area of lysed zones for experimental and reference samples is determined. When average total area of experimental lysed zones exceeds average total area of reference lysed zones by 5% minimum, phagoimmunoassay is considered positive.
EFFECT: efficient method for evaluating phagoimmunotest results.
4 tbl, 5 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ANTIGENS ASSAY | 1991 |
|
RU2006036C1 |
| METHOD OF TREATMENT OF INFECTION RELATED TO THE PROVISION OF MEDICAL ASSISTANCE CAUSED BY A CAUSATIVE AGENT OR PATHOGENS WITH MULTIPLE DRUG RESISTANCE | 2017 |
|
RU2664681C1 |
| ANTIBACTERIAL COMPOSITION IN FORM OF SUPPOSITORY AND METHOD OF ITS PREPARATION | 2016 |
|
RU2622762C1 |
| COMBINATORIAL FRAGMID LIBRARY OF HUMAN SINGLE-STRANDED ANTIBODIES ENRICHED WITH ANTIBODIES AGAINST VARIOLOVACCINE VIRUS, RECOMBINANT FRAGMID pHEN-2A8 DNA CONTAINING UNIQUE GENE OF HUMAN SINGLE-STRANDED ANTIBODY, CAPABLE OF NEUTRALIZING VARIOLOVACCINE VIRUS AND COWPOX VIRUS, AND ARTIFICIAL HUMAN SINGLE-STRANDED 2A8 ANTIBODY CAPABLE OF NEUTRALIZING VARIOLOVACCINE VIRUS AND COWPOX VIRUS | 2005 |
|
RU2311927C2 |
| RECOMBINANT FRAGMID DNA pHEN-TAB CONTAINING HUMAN SINGLE-STRAND ANTIBODY GENE, CAPABLE OF BINDING OF HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT Escherichia coli BACTERIA STRAIN AS PRODUCER OF HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT SOLUBLE HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA | 2005 |
|
RU2307163C2 |
| HUMANIZED ANTIBODY TO CD52 | 2012 |
|
RU2605307C2 |
| AGENT FOR NEUTRALISING SMALLPOX VIRUS | 2013 |
|
RU2515905C1 |
| CONSTRUCTION OF MODIFIED FILAMENTOUS BACTERIOPHAGE FOR TREATMENT OR PROPHYLAXIS OF BACTERIAL INFECTION, MODIFIED BACTERIOPHAGE M14, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF BACTERIAL INFECTION, MONOCLONAL ANTIBODY, HYBRIDOMA (VARIANT) | 1997 |
|
RU2215032C2 |
| METHOD OF ASSAY OF ANTIBODY RAISED TO CHICKEN REOVIRAL TENOSYNOVITIS ANTIGEN | 2000 |
|
RU2192012C2 |
| METHOD OF DETERMINATION OF SPECIFIC ANTIBODIES TO VIRUS OF GOOSE ENTERITIS | 2006 |
|
RU2323743C2 |
